PEPROTECH INC.

Company Snapshot

Founded: 1988
Entity Type: Private
Employees: 100
Region: U.S.
Headquarter: New Jersey, U.S.
Key Geographics: U.S., Europe, Asia-Pacific
Corporate Address: 5 Cedarbrook Drive Cranbury, New Jersey, 08512 U.S. Tel. +1-800-436-9910 www.peprotech.com

Company Overview

PeproTech was founded in 1988 by a group of scientists to develop and produce recombinant cytokines for life science research. PeproTech is a leading supplier of cytokine products, including E. coli, insect, and mammalian cell-derived recombinant proteins, their monoclonal/polyclonal antibodies, ELISA development kits, cell culture media/supplements, and other cytokine-related reagents. With over 2,000 products, PeproTech also offers growth factors, culture media, and characterization kits for iPSC research. The firm has state-of-the-art manufacturing facilities in the U.S. and offices around the world.

PEPROTECH INC. In Reports

Induced Pluripotent Stem Cells: Global Markets

BCC Research Market Report says global market for induced pluripotent stem cells is expected to grow from $3.4 billion in 2023 and forecast to reach $5.2 billion by the end of 2028 at a CAGR of 9.1%.

Global Markets for Media, Sera and Reagents in Biotechnology

BCC Research Market Report for Media, Sera and Reagents in Biotechnology Market. Global market trends, with CAGRs through 2026.

Induced Pluripotent Stem Cells: Global Markets

BCC Research Market Report says induced pluripotent stem cells should grow from $2.8 billion in 2021 to $4.4 billion by 2026, at compound annual growth rate of 9.3%.

Company's Business Segments

  • Products : GMP Cytokines, RUO Cytokines, Antibodies, ELISA Kits.

Applications/End User Industries

  • Healthcare
  • Cell Diagnostics
  • Biomedical
  • Biotechnology